{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T04:17:18Z","timestamp":1794629838138,"version":"4.9.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI073755"],"award-info":[{"award-number":["R01 AI073755"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93019C00062"],"award-info":[{"award-number":["75N93019C00062"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","id":[{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>There are no licensed therapeutics or vaccines available against Zika virus (ZIKV) to counteract its potential for congenital disease. Antibody-based countermeasures targeting the ZIKV envelope protein have been hampered by concerns for cross-reactive responses that induce antibody-dependent enhancement (ADE) of heterologous flavivirus infection. Nonstructural protein 1 (NS1) is a membrane-associated and secreted glycoprotein that functions in flavivirus replication and immune evasion but is absent from the virion. Although some studies suggest that antibodies against ZIKV NS1 are protective, their activity during congenital infection is unknown. Here we develop mouse and human anti-NS1 monoclonal antibodies that protect against ZIKV in both non-pregnant and pregnant mice. Avidity of antibody binding to cell-surface NS1 along with Fc effector functions engagement correlate with protection in vivo. Protective mAbs map to exposed epitopes in the wing domain and loop face of the \u03b2-platform. Anti-NS1 antibodies provide an alternative strategy for protection against congenital ZIKV infection without causing ADE.<\/jats:p>","DOI":"10.1038\/s41467-020-19096-y","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T06:09:45Z","timestamp":1603087785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancy"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0438-7842","authenticated-orcid":false,"given":"Alex W.","family":"Wessel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurgun","family":"Kose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin G.","family":"Bombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5064-1098","authenticated-orcid":false,"given":"Vicky","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warangkana","family":"Chantima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3416-9480","authenticated-orcid":false,"given":"Juthathip","family":"Mongkolsapaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Edeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7680-9215","authenticated-orcid":false,"given":"Galit","family":"Alter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3549-4309","authenticated-orcid":false,"given":"Gavin R.","family":"Screaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8544-2689","authenticated-orcid":false,"given":"David H.","family":"Fremont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0049-1079","authenticated-orcid":false,"suffix":"Jr","given":"James E.","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8791-3165","authenticated-orcid":false,"given":"Michael S.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"key":"19096_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41559-019-0836-z","volume":"3","author":"G Gutierrez-Bugallo","year":"2019","unstructured":"Gutierrez-Bugallo, G. et al. Vector-borne transmission and evolution of Zika virus. Nat. Ecol. Evol. 3, 561\u2013569 (2019).","journal-title":"Nat. Ecol. Evol."},{"key":"19096_CR2","doi-asserted-by":"publisher","first-page":"4864","DOI":"10.1128\/JVI.00252-16","volume":"90","author":"HM Lazear","year":"2016","unstructured":"Lazear, H. M. & Diamond, M. S. Zika virus: new clinical syndromes and its emergence in the Western Hemisphere. J. Virol. 90, 4864\u20134875 (2016).","journal-title":"J. Virol."},{"key":"19096_CR3","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1056\/NEJMc1602964","volume":"374","author":"G Carteaux","year":"2016","unstructured":"Carteaux, G. et al. Zika virus associated with meningoencephalitis. N. Engl. J. Med. 374, 1595\u20131596 (2016).","journal-title":"N. Engl. J. Med."},{"key":"19096_CR4","doi-asserted-by":"publisher","unstructured":"Oehler, E. et al. Zika virus infection complicated by Guillain-Barre syndrome-case report, French Polynesia, December 2013. Euro Surveill. 19, https:\/\/doi.org\/10.2807\/1560-7917.es2014.19.9.20720 (2014).","DOI":"10.2807\/1560-7917.es2014.19.9.20720"},{"key":"19096_CR5","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","volume":"387","author":"VM Cao-Lormeau","year":"2016","unstructured":"Cao-Lormeau, V. M. et al. Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387, 1531\u20131539 (2016).","journal-title":"Lancet"},{"key":"19096_CR6","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1056\/NEJMoa1602412","volume":"375","author":"P Brasil","year":"2016","unstructured":"Brasil, P. et al. Zika virus infection in pregnant women in Rio de Janeiro. N. Engl. J. Med. 375, 2321\u20132334 (2016).","journal-title":"N. Engl. J. Med."},{"key":"19096_CR7","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.cell.2016.05.008","volume":"165","author":"JJ Miner","year":"2016","unstructured":"Miner, J. J. et al. Zika virus infection during pregnancy in mice causes placental damage and fetal demise. Cell 165, 1081\u20131091 (2016).","journal-title":"Cell"},{"key":"19096_CR8","doi-asserted-by":"publisher","first-page":"9608","DOI":"10.1128\/JVI.71.12.9608-9617.1997","volume":"71","author":"BD Lindenbach","year":"1997","unstructured":"Lindenbach, B. D. & Rice, C. M. trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication. J. Virol. 71, 9608\u20139617 (1997).","journal-title":"J. Virol."},{"key":"19096_CR9","doi-asserted-by":"publisher","first-page":"7360","DOI":"10.1128\/JVI.00157-12","volume":"86","author":"S Youn","year":"2012","unstructured":"Youn, S. et al. Evidence for a genetic and physical interaction between nonstructural proteins NS1 and NS4B that modulates replication of West Nile virus. J. Virol. 86, 7360\u20137371 (2012).","journal-title":"J. Virol."},{"key":"19096_CR10","doi-asserted-by":"publisher","first-page":"e1007736","DOI":"10.1371\/journal.ppat.1007736","volume":"15","author":"A Plaszczyca","year":"2019","unstructured":"Plaszczyca, A. et al. A novel interaction between dengue virus nonstructural protein 1 and the NS4A-2K-4B precursor is required for viral RNA replication but not for formation of the membranous replication organelle. PLoS Pathog. 15, e1007736 (2019).","journal-title":"PLoS Pathog."},{"key":"19096_CR11","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/0042-6822(89)90544-8","volume":"171","author":"G Winkler","year":"1989","unstructured":"Winkler, G., Maxwell, S. E., Ruemmler, C. & Stollar, V. Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization. Virology 171, 302\u2013305 (1989).","journal-title":"Virology"},{"key":"19096_CR12","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1099\/vir.0.83620-0","volume":"89","author":"S Noisakran","year":"2008","unstructured":"Noisakran, S. et al. Association of dengue virus NS1 protein with lipid rafts. J. Gen. Virol. 89, 2492\u20132500 (2008).","journal-title":"J. Gen. Virol."},{"key":"19096_CR13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.antiviral.2013.03.008","volume":"98","author":"DA Muller","year":"2013","unstructured":"Muller, D. A. & Young, P. R. The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker. Antivir. Res. 98, 192\u2013208 (2013).","journal-title":"Antivir. Res."},{"key":"19096_CR14","doi-asserted-by":"publisher","first-page":"19111","DOI":"10.1073\/pnas.0605668103","volume":"103","author":"KM Chung","year":"2006","unstructured":"Chung, K. M. et al. West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proc. Natl Acad. Sci. USA 103, 19111\u201319116 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"19096_CR15","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1084\/jem.20092545","volume":"207","author":"P Avirutnan","year":"2010","unstructured":"Avirutnan, P. et al. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. J. Exp. Med. 207, 793\u2013806 (2010).","journal-title":"J. Exp. Med."},{"key":"19096_CR16","doi-asserted-by":"publisher","first-page":"424","DOI":"10.4049\/jimmunol.1100750","volume":"187","author":"P Avirutnan","year":"2011","unstructured":"Avirutnan, P. et al. Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation. J. Immunol. 187, 424\u2013433 (2011).","journal-title":"J. Immunol."},{"key":"19096_CR17","doi-asserted-by":"publisher","first-page":"9570","DOI":"10.1128\/JVI.00912-16","volume":"90","author":"JN Conde","year":"2016","unstructured":"Conde, J. N. et al. Inhibition of the membrane attack complex by dengue virus NS1 through interaction with vitronectin and terminal complement proteins. J. Virol. 90, 9570\u20139581 (2016).","journal-title":"J. Virol."},{"key":"19096_CR18","doi-asserted-by":"publisher","first-page":"304ra142","DOI":"10.1126\/scitranslmed.aaa3863","volume":"7","author":"N Modhiran","year":"2015","unstructured":"Modhiran, N. et al. Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity. Sci. Transl. Med. 7, 304ra142 (2015).","journal-title":"Sci. Transl. Med."},{"key":"19096_CR19","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/icb.2017.5","volume":"95","author":"N Modhiran","year":"2017","unstructured":"Modhiran, N. et al. Dengue virus NS1 protein activates immune cells via TLR4 but not TLR2 or TLR6. Immunol. Cell Biol. 95, 491\u2013495 (2017).","journal-title":"Immunol. Cell Biol."},{"key":"19096_CR20","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1128\/JCM.38.3.1053-1057.2000","volume":"38","author":"PR Young","year":"2000","unstructured":"Young, P. R., Hilditch, P. A., Bletchly, C. & Halloran, W. An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J. Clin. Microbiol. 38, 1053\u20131057 (2000).","journal-title":"J. Clin. Microbiol."},{"key":"19096_CR21","doi-asserted-by":"publisher","first-page":"eaan1589","DOI":"10.1126\/scitranslmed.aan1589","volume":"9","author":"I Bosch","year":"2017","unstructured":"Bosch, I. et al. Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum. Sci. Transl. Med. 9, eaan1589 (2017).","journal-title":"Sci. Transl. Med."},{"key":"19096_CR22","doi-asserted-by":"publisher","first-page":"13924","DOI":"10.1128\/JVI.79.22.13924-13933.2005","volume":"79","author":"J Macdonald","year":"2005","unstructured":"Macdonald, J. et al. NS1 protein secretion during the acute phase of West Nile Virus infection. J. Virol. 79, 13924\u201313933 (2005).","journal-title":"J. Virol."},{"key":"19096_CR23","doi-asserted-by":"publisher","first-page":"16087","DOI":"10.1038\/nmicrobiol.2016.87","volume":"1","author":"J Liu","year":"2016","unstructured":"Liu, J. et al. Flavivirus NS1 protein in infected host sera enhances viral acquisition by mosquitoes. Nat. Microbiol. 1, 16087\u201316087 (2016).","journal-title":"Nat. Microbiol."},{"key":"19096_CR24","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nature22365","volume":"545","author":"Y Liu","year":"2017","unstructured":"Liu, Y. et al. Evolutionary enhancement of Zika virus infectivity in Aedes aegypti mosquitoes. Nature 545, 482\u2013486 (2017).","journal-title":"Nature"},{"key":"19096_CR25","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1371\/journal.ppat.0030183","volume":"3","author":"P Avirutnan","year":"2007","unstructured":"Avirutnan, P. et al. Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. PLoS Pathog. 3, e183 (2007).","journal-title":"PLoS Pathog."},{"key":"19096_CR26","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.celrep.2019.01.036","volume":"26","author":"H Puerta-Guardo","year":"2019","unstructured":"Puerta-Guardo, H. et al. Flavivirus NS1 triggers tissue-specific vascular endothelial dysfunction reflecting disease tropism. Cell Rep. 26, 1598\u20131613 .e1598 (2019).","journal-title":"Cell Rep."},{"key":"19096_CR27","doi-asserted-by":"publisher","first-page":"304ra141","DOI":"10.1126\/scitranslmed.aaa3787","volume":"7","author":"PR Beatty","year":"2015","unstructured":"Beatty, P. R. et al. Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Sci. Transl. Med. 7, 304ra141\u2013304ra141 (2015).","journal-title":"Sci. Transl. Med."},{"key":"19096_CR28","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/infdis\/jiz331","volume":"221","author":"H Puerta-Guardo","year":"2020","unstructured":"Puerta-Guardo, H. et al. Zika virus nonstructural protein 1 disrupts glycosaminoglycans and causes permeability in developing human placentas. J. Infect. Dis. 221, 313\u2013324 (2020).","journal-title":"J. Infect. Dis."},{"key":"19096_CR29","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1126\/science.1247749","volume":"343","author":"DL Akey","year":"2014","unstructured":"Akey, D. L. et al. Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system. Science 343, 881\u2013885 (2014).","journal-title":"Science"},{"key":"19096_CR30","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1073\/pnas.1322036111","volume":"111","author":"MA Edeling","year":"2014","unstructured":"Edeling, M. A., Diamond, M. S. & Fremont, D. H. Structural basis of Flavivirus NS1 assembly and antibody recognition. Proc. Natl Acad. Sci. USA 111, 4285\u20134290 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"19096_CR31","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nsmb.3268","volume":"23","author":"WC Brown","year":"2016","unstructured":"Brown, W. C. et al. Extended surface for membrane association in Zika virus NS1 structure. Nat. Struct. Mol. Biol. 23, 865\u2013867 (2016).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"19096_CR32","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.15252\/embj.201695290","volume":"35","author":"X Xu","year":"2016","unstructured":"Xu, X. et al. Contribution of intertwined loop to membrane association revealed by Zika virus full-length NS1 structure. EMBO J. 35, 2170\u20132178 (2016).","journal-title":"EMBO J."},{"key":"19096_CR33","doi-asserted-by":"publisher","first-page":"8003","DOI":"10.1073\/pnas.1017338108","volume":"108","author":"I Gutsche","year":"2011","unstructured":"Gutsche, I. et al. Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein. Proc. Natl Acad. Sci. USA 108, 8003\u20138008 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"19096_CR34","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1006\/viro.1993.1015","volume":"192","author":"JJ Schlesinger","year":"1993","unstructured":"Schlesinger, J. J., Foltzer, M. & Chapman, S. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice. Virology 192, 132\u2013141 (1993).","journal-title":"Virology"},{"key":"19096_CR35","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1128\/JVI.80.3.1340-1351.2006","volume":"80","author":"KM Chung","year":"2006","unstructured":"Chung, K. M. et al. Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms. J. Virol. 80, 1340\u20131351 (2006).","journal-title":"J. Virol."},{"key":"19096_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1099\/vir.0.036640-0","volume":"93","author":"TH Lee","year":"2012","unstructured":"Lee, T. H. et al. A cross-protective mAb recognizes a novel epitope within the flavivirus NS1 protein. J. Gen. Virol. 93, 20\u201326 (2012).","journal-title":"J. Gen. Virol."},{"key":"19096_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07008-0","volume":"9","author":"MJ Bailey","year":"2018","unstructured":"Bailey, M. J. et al. Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model. Nat. Commun. 9, 4560 (2018).","journal-title":"Nat. Commun."},{"key":"19096_CR38","doi-asserted-by":"publisher","unstructured":"Bailey, M. J. et al. Antibodies elicited by an NS1-based vaccine protect mice against Zika Virus. mBio 10, https:\/\/doi.org\/10.1128\/mBio.02861-18 (2019).","DOI":"10.1128\/mBio.02861-18"},{"key":"19096_CR39","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.chom.2018.04.003","volume":"23","author":"MJ Gorman","year":"2018","unstructured":"Gorman, M. J. et al. An immunocompetent mouse model of Zika virus infection. Cell Host Microbe 23, 672\u2013685 (2018). e676.","journal-title":"Cell Host Microbe"},{"key":"19096_CR40","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature20564","volume":"540","author":"G Sapparapu","year":"2016","unstructured":"Sapparapu, G. et al. Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice. Nature 540, 443 (2016).","journal-title":"Nature"},{"key":"19096_CR41","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.chom.2016.03.010","volume":"19","author":"HM Lazear","year":"2016","unstructured":"Lazear, H. M. et al. A mouse model of Zika virus pathogenesis. Cell Host Microbe 19, 720\u2013730 (2016).","journal-title":"Cell Host Microbe"},{"key":"19096_CR42","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.4049\/jimmunol.179.5.2815","volume":"179","author":"Y Tang","year":"2007","unstructured":"Tang, Y. et al. Regulation of antibody-dependent cellular cytotoxicity by IgG intrinsic and apparent affinity for target antigen. J. Immunol. 179, 2815\u20132823 (2007).","journal-title":"J. Immunol."},{"key":"19096_CR43","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1365-3083.1981.tb00163.x","volume":"13","author":"C \u00d6hlandlr","year":"1981","unstructured":"\u00d6hlandlr, C., Larsson, \u00c5. & Perlmann, P. Regulation of effector functions of human K-cells and monocytes by antigen density of the target cells. Scand. J. Immunol. 13, 503\u2013510 (1981).","journal-title":"Scand. J. Immunol."},{"key":"19096_CR44","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.4049\/jimmunol.1200501","volume":"190","author":"A Lux","year":"2013","unstructured":"Lux, A., Yu, X., Scanlan, C. N. & Nimmerjahn, F. Impact of immune complex size and glycosylation on IgG binding to human Fc\u03b3Rs. J. Immunol. 190, 4315\u20134323 (2013).","journal-title":"J. Immunol."},{"key":"19096_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.1991.tb08115.x","volume":"84","author":"YM Lucisano Valim","year":"1991","unstructured":"Lucisano Valim, Y. M. & Lachmann, P. J. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions. Clin. Exp. Immunol. 84, 1\u20138 (1991).","journal-title":"Clin. Exp. Immunol."},{"key":"19096_CR46","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1084\/jem.20151267","volume":"212","author":"S Bournazos","year":"2015","unstructured":"Bournazos, S., DiLillo, D. J. & Ravetch, J. V. The role of Fc-FcgammaR interactions in IgG-mediated microbial neutralization. J. Exp. Med. 212, 1361\u20131369 (2015).","journal-title":"J. Exp. Med."},{"key":"19096_CR47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/imm.12323","volume":"143","author":"E Davidson","year":"2014","unstructured":"Davidson, E. & Doranz, B. J. A high-throughput shotgun mutagenesis approach to mapping B-cell antibody epitopes. Immunology 143, 13\u201320 (2014).","journal-title":"Immunology"},{"key":"19096_CR48","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.4049\/jimmunol.1700029","volume":"198","author":"T Hertz","year":"2017","unstructured":"Hertz, T. et al. Antibody epitopes identified in critical regions of dengue virus nonstructural 1 protein in mouse vaccination and natural human infections. J. Immunol. 198, 4025\u20134035 (2017).","journal-title":"J. Immunol."},{"issue":"Pt 12","key":"19096_CR49","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1099\/0022-1317-75-12-3453","volume":"75","author":"AJ Crooks","year":"1994","unstructured":"Crooks, A. J., Lee, J. M., Easterbrook, L. M., Timofeev, A. V. & Stephenson, J. R. The NS1 protein of tick-borne encephalitis virus forms multimeric species upon secretion from the host cell. J. Gen. Virol. 75(Pt 12), 3453\u20133460 (1994).","journal-title":"J. Gen. Virol."},{"key":"19096_CR50","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1006\/viro.1993.1318","volume":"194","author":"MJ Pryor","year":"1993","unstructured":"Pryor, M. J. & Wright, P. J. The effects of site-directed mutagenesis on the dimerization and secretion of the NS1 protein specified by dengue virus. Virology 194, 769\u2013780 (1993).","journal-title":"Virology"},{"key":"19096_CR51","doi-asserted-by":"publisher","first-page":"9551","DOI":"10.1128\/JVI.00879-07","volume":"81","author":"KM Chung","year":"2007","unstructured":"Chung, K. M., Thompson, B. S., Fremont, D. H. & Diamond, M. S. Antibody recognition of cell surface-associated NS1 triggers Fc-\u03b3 receptor-mediated phagocytosis and clearance of West Nile virus-infected cells. J. Virol. 81, 9551\u20139555 (2007).","journal-title":"J. Virol."},{"key":"19096_CR52","doi-asserted-by":"publisher","first-page":"989","DOI":"10.4269\/ajtmh.14-0162","volume":"92","author":"HJ Cheng","year":"2015","unstructured":"Cheng, H. J. et al. Correlation between serum levels of anti-endothelial cell autoantigen and anti-dengue virus nonstructural protein 1 antibodies in dengue patients. Am. J. Trop. Med. Hyg. 92, 989\u2013995 (2015).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"19096_CR53","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.4049\/jimmunol.1500057","volume":"196","author":"YC Chuang","year":"2016","unstructured":"Chuang, Y. C., Lin, J., Lin, Y. S., Wang, S. & Yeh, T. M. Dengue virus nonstructural protein 1-induced antibodies cross-react with human plasminogen and enhance its activation. J. Immunol. 196, 1218\u20131226 (2016).","journal-title":"J. Immunol."},{"key":"19096_CR54","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.molimm.2009.08.033","volume":"47","author":"HJ Cheng","year":"2009","unstructured":"Cheng, H. J. et al. Anti-dengue virus nonstructural protein 1 antibodies recognize protein disulfide isomerase on platelets and inhibit platelet aggregation. Mol. Immunol. 47, 398\u2013406 (2009).","journal-title":"Mol. Immunol."},{"key":"19096_CR55","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/S1473-3099(18)30397-9","volume":"18","author":"S Sivapalasingam","year":"2018","unstructured":"Sivapalasingam, S. et al. Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 study. Lancet Infect. Dis. 18, 884\u2013893 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"19096_CR56","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.immuni.2020.01.001","volume":"52","author":"P Gilchuk","year":"2020","unstructured":"Gilchuk, P. et al. Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization. Immunity 52, 388\u2013403 (2020). e312.","journal-title":"Immunity"},{"key":"19096_CR57","doi-asserted-by":"publisher","first-page":"e1003312","DOI":"10.1371\/journal.ppat.1003312","volume":"9","author":"P Pal","year":"2013","unstructured":"Pal, P. et al. Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus. PLoS Pathog. 9, e1003312 (2013).","journal-title":"PLoS Pathog."},{"key":"19096_CR58","doi-asserted-by":"publisher","unstructured":"Saunders, K. O. Conceptual approaches to modulating antibody effector functions and circulation half-life. Front. Immunol. 10, https:\/\/doi.org\/10.3389\/fimmu.2019.01296 (2019).","DOI":"10.3389\/fimmu.2019.01296"},{"key":"19096_CR59","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2016.07.020","volume":"166","author":"H Zhao","year":"2016","unstructured":"Zhao, H. et al. Structural basis of Zika virus-specific antibody protection. Cell 166, 1016\u20131027 (2016).","journal-title":"Cell"},{"key":"19096_CR60","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/ni.3849","volume":"18","author":"E Fernandez","year":"2017","unstructured":"Fernandez, E. et al. Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection. Nat. Immunol. 18, 1261\u20131269 (2017).","journal-title":"Nat. Immunol."},{"key":"19096_CR61","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1126\/science.aal4365","volume":"356","author":"SV Bardina","year":"2017","unstructured":"Bardina, S. V. et al. Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science 356, 175\u2013180 (2017).","journal-title":"Science"},{"key":"19096_CR62","doi-asserted-by":"publisher","unstructured":"Katzelnick, L. C. et al. Antibody-dependent enhancement of severe dengue disease in humans. Science, eaan6836, https:\/\/doi.org\/10.1126\/science.aan6836 (2017).","DOI":"10.1126\/science.aan6836"},{"key":"19096_CR63","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.4049\/jimmunol.135.4.2805","volume":"135","author":"JJ Schlesinger","year":"1985","unstructured":"Schlesinger, J. J., Brandriss, M. W. & Walsh, E. E. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. J. Immunol. 135, 2805\u2013gp2809 (1985).","journal-title":"J. Immunol."},{"key":"19096_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15039-8","volume":"7","author":"AC Brault","year":"2017","unstructured":"Brault, A. C. et al. A Zika vaccine targeting NS1 pprotects immunocompetent adult mice in a lethal challenge model. Sci. Rep. 7, 14769 (2017).","journal-title":"Sci. Rep."},{"key":"19096_CR65","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1128\/JVI.66.4.2086-2095.1992","volume":"66","author":"SC Jacobs","year":"1992","unstructured":"Jacobs, S. C., Stephenson, J. R. & Wilkinson, G. W. High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector: protection elicited in a murine model. J. Virol. 66, 2086\u20132095 (1992).","journal-title":"J. Virol."},{"key":"19096_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-018-0072-6","volume":"3","author":"X Liu","year":"2018","unstructured":"Liu, X. et al. Incorporation of NS1 and prM\/M are important to confer effective protection of adenovirus-vectored Zika virus vaccine carrying E protein. npj Vaccines 3, 29 (2018).","journal-title":"npj Vaccines"},{"key":"19096_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05276-4","volume":"9","author":"A Li","year":"2018","unstructured":"Li, A. et al. A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein. Nat. Commun. 9, 3067 (2018).","journal-title":"Nat. Commun."},{"key":"19096_CR68","first-page":"e00009","volume":"91","author":"TE Morrison","year":"2017","unstructured":"Morrison, T. E. & Diamond, M. S. Animal models of Zika virus infection, pathogenesis, and immunity. J. Virol. 91, e00009\u2013e00017 (2017).","journal-title":"J. Virol."},{"key":"19096_CR69","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3201\/eid1705.101939","volume":"17","author":"BD Foy","year":"2011","unstructured":"Foy, B. D. et al. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg. Infect. Dis. 17, 880\u2013882 (2011).","journal-title":"Emerg. Infect. Dis."},{"key":"19096_CR70","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ni.3058","volume":"16","author":"W Dejnirattisai","year":"2015","unstructured":"Dejnirattisai, W. et al. A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat. Immunol. 16, 170\u2013177 (2015).","journal-title":"Nat. Immunol."},{"key":"19096_CR71","doi-asserted-by":"crossref","first-page":"15D.13.11","DOI":"10.1002\/9780471729259.mc15d03s31","volume":"31","author":"JD Brien","year":"2013","unstructured":"Brien, J. D., Lazear, H. M. & Diamond, M. S. Propagation, quantification, detection, and storage of West Nile virus. Curr. Protoc. Microbiol. 31, 15D.13.11\u201315D.13.18 (2013).","journal-title":"Curr. Protoc. Microbiol."},{"key":"19096_CR72","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.pep.2005.01.016","volume":"41","author":"FW Studier","year":"2005","unstructured":"Studier, F. W. Protein production by auto-induction in high-density shaking cultures. Protein Expr. Purif. 41, 207\u2013234 (2005).","journal-title":"Protein Expr. Purif."},{"key":"19096_CR73","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1089\/jir.2006.26.804","volume":"26","author":"KC Sheehan","year":"2006","unstructured":"Sheehan, K. C. et al. Blocking monoclonal antibodies specific for mouse IFN-alpha\/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection. J. Interferon Cytokine Res. 26, 804\u2013819 (2006).","journal-title":"J. Interferon Cytokine Res."},{"key":"19096_CR74","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nm1240","volume":"11","author":"T Oliphant","year":"2005","unstructured":"Oliphant, T. et al. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat. Med. 11, 522\u2013530 (2005).","journal-title":"Nat. Med."},{"key":"19096_CR75","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nprot.2009.3","volume":"4","author":"K Smith","year":"2009","unstructured":"Smith, K. et al. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat. Protoc. 4, 372\u2013384 (2009).","journal-title":"Nat. Protoc."},{"key":"19096_CR76","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","volume":"329","author":"T Tiller","year":"2008","unstructured":"Tiller, T. et al. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J. Immunol. Methods 329, 112\u2013124 (2008).","journal-title":"J. Immunol. Methods"},{"key":"19096_CR77","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1172\/JCI80693","volume":"125","author":"JR Willis","year":"2015","unstructured":"Willis, J. R. et al. Redesigned HIV antibodies exhibit enhanced neutralizing potency and breadth. J. Clin. Invest. 125, 2523\u20132531 (2015).","journal-title":"J. Clin. Invest."},{"key":"19096_CR78","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41564-018-0286-4","volume":"4","author":"AS Kim","year":"2019","unstructured":"Kim, A. S. et al. Protective antibodies against Eastern equine encephalitis virus bind to epitopes in domains A and B of the E2 glycoprotein. Nat. Microbiol. 4, 187\u2013197 (2019).","journal-title":"Nat. Microbiol."},{"key":"19096_CR79","doi-asserted-by":"publisher","first-page":"W320","DOI":"10.1093\/nar\/gku316","volume":"42","author":"X Robert","year":"2014","unstructured":"Robert, X. & Gouet, P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 42, W320\u2013W324 (2014).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19096-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19096-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19096-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T22:30:53Z","timestamp":1696890653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19096-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["19096"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-19096-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]},"assertion":[{"value":"7 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.S.D. is a consultant for Inbios, Vir Biotechnology, NGM Biopharmaceuticals, Carnival Corporation\u00a0and on the Scientific Advisory Board of Moderna and Immunome. The Diamond laboratory has received unrelated funding support in sponsored research agreements from Moderna, Vir Biotechnology, and Emergent BioSolutions. J.E.C. has served as a consultant for Takeda Vaccines, Sanofi-Aventis., Pfizer, and Novavax, is a member of the Scientific Advisory Boards of CompuVax and Meissa Vaccines, and is\u00a0the founder of IDBiologics. G.R.S. is on the Scientific Advisory Board for GSK Vaccines. G.A. is a founder of Systems Seromyx Inc. The Alter laboratory has received funding from Janssen, Merck, Sanofi, Pfizer, GlaxoSmithKline, Bristol Myers Squibb, and Gilead. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5278"}}